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A B S T R A C T
Rare malignant tumor of the salivary gland, a myoepithelial carcinoma, arose de novo in the right parotid gland. The
initial tumor was composed predominantly of myoepithelial cells. Subsequently the tumor recurred three times, with in-
filtration of the bones of the cranial base. Histological examination showed sarcomatoid neoplasm composed of malig-
nant spindle cells with high mitotic rate and perineural invasion. There was no involvement of cervical lymph nodes.
Immunohistochemistry demonstrated myoepithelial differentiation: tumor cells were positively stained with vimentin,
alpha smooth muscle actin and S-100 protein antibodies, and focal positively was noticed with cytokeratin (AE1/AE3)
antibody. Large number of tumor cells nuclei was reactive with the monoclonal anti-p63 antibody, clone 4A4. Myoepithe-
lial carcinomas exhibit a wide spectrum of morphological heterogeneity and for that reason could be confused with many
tumors. Cytoarchitectural patterns and immunohistochemical profile are crucial for identification. These tumors are
malignant neoplasms with diverse clinical outcomes, sometimes very aggressive.
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Introduction
Myoepithelial carcinoma or malignant myoepithelio-
ma of the salivary glands is a rare tumor and represents
the malignant counterpart of benign myoepithelioma1.
The predominant differentiation of the tumor cells is
myoepithelial. Cells demonstrate cytological atypia and a
potential for aggressive behavior2. The sex incidence is
approximately equal and the average age of patients at
presentation is about 55 years. One-half of cases arise
from a pre-existing pleomorphic adenoma or myoepithe-
lioma, particularly in recurrences3–5. In this report we
present a morphological and immunohistochemical anal-
ysis of a myoepithelial carcinoma which arose de novo in
a parotid gland and had a very aggressive behavior.
Case Report
A 66-year old man presented with a two months his-
tory of painless swelling in the right preauricular region.
On examination, a 3.5 cm diameter firm tumor mass was
palpable in the parotid gland. On radiological and ultra-
sound examination there was no evidence of bone erosion
or extension of tumor. A right superficial parotidectomy
was performed. Postoperatively the patient made a good
recovery, with full facial nerve function. Two months
later a recurrent mass developed in the region of the pre-
vious scar. The mass was resected. One month later com-
puted tomography (CT) confirmed the presence of recur-
rent tumor consisting of one satellite nodule of 1 cm
diameter in the deep lobe of the parotid gland posteriorly.
Patient underwent a right radical parotidectomy with
sacrifice of the facial nerve and elective right neck dissec-
tion. Seven months later he complained of a headache
and diplopia. Magnetic resonance imaging (MRI) and CT
revealed a large tumor in the cavernous sinus extending
into the pituitary fossa, the right pterygopalatine fossa
and right orbit, with bone erosion. The transmaxillary
biopsy confirmed the presence of recurrent tumor. The
patient received palliative radiotherapy and he died of
disease two months later, just 14 months after first
symptoms occurred.
The surgical specimens were fixed in formalin. Sec-
tions for histological examination were routinely pro-
cessed in paraffin wax and stained with haematoxylin
and eosin. Immunohistocemical staining was performed
using a standard streptavidin-biotin-peroxidase method
(Dako, Glostrup, Denmark). The following monoclonal
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antibodies were used: cytokeratin AE1/AE3 (Dako), S-100
protein (Dako), alpha smooth muscle actin (Dako), vimen-
tin (Dako), epithelial membrane antigen (EMA, Dako),
HMB-45 (Dako), Ki-67 (Dako) and p63, clone 4A4 (Dako).
The initial resection specimen contained a firm, whit-
ish tumor tissue measuring 4 cm in maximum dimen-
sion, with a thick irregular border. Histological examina-
tion showed cellular tumor composed predominantly of
cells with ovoid to spindle shaped nuclei, with a moderate
amount of cytoplasm, which was either clear or eosino-
philic. There was an abundant myxoid stroma between
tumor cells (Figure 1a). Small areas of epithelial ele-
ments consisting of ducts and tubules were focally pres-
ent. In some areas mitotic count was high – there were
10–20 mitoses per 10 high power fields. Tumor was not
present at the surgical resection margins.
The resection specimen of the first recurrence con-
sisted of a tumor measuring 2 cm in maximum dimen-
sion. Histological examination showed that the tumor
was composed of the solid areas similar to those seen in
the initial specimen, with higher mitotic index. The
perineural invasion and areas of necrosis were present.
Tumor was present at the surgical resection margin. The
second resected recurrence consisted of the skin, residual
parotid gland with a tumor measuring 1.5 cm in maxi-
mum dimension and cervical lymph nodes. Histological
examination showed a sarcomatoid tumor composed al-
most entirely of spindle cells with myxoid stroma be-
tween tumor cells. Surgical resection margins and cervi-
cal lymph nodes were free of tumor. The third recurrence
of the tumor was confirmed by transmaxillary biopsy and
the histological findings were similar to the previous.
In the first and second resection ducts and tubules of
the tumor were immunoreactive for cytokeratin (AE1/AE3),
EMA and S-100 but negative with the other antibodies.
The spindle-cell tumor areas in the initial specimen and
in all recurrences were highly positive for vimentin anti-
bodies and focally positive with S-100 protein and alpha
smooth muscle actin. These tumor cells were negative
with the antibodies for cytokeratin (AE1/AE3), EMA,
HMB-45 and CEA. The tumor cells nuclei were immu-
noreactive with Ki-67. In the initial specimen the mean
proliferation index was 10% and in all recurrences the
mean index was 20%.
The tumor cells nuclei in the initial specimen and in
all recurrence specimens stained diffusely positive with
monoclonal anti-p63 antibody, clone 4A4.
Discussion
The malignant counterpart of benign myoepithelioma
– myoepithelial carcinoma or malignant myoepithelioma,
is rare neoplasm and is one of several new entities in-
cluded in the updated classification of salivary gland
neoplasms (World Health Organization, 19912). Most
commonly it involves the parotid gland, but other mayor
or minor glands and the breast can also be affected3,6,7.
Two criteria must be satisfied to establish a diagnosis of
myoepithelial carcinoma: the neoplastic cells must show
myoepithelial differentiation and the tumor must be
malignant8. In the present case, myoepithelial differenti-
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Fig. 1. Myoepithelial carcinoma. a) stained with HE method, objective 20X b) Ki-67 antibody, objective 20X c) p63 antibody, clone 4A4,
objective 20X d) S 100 protein antibody, objective 20X.
ation was established by cytoarchitectural patterns and
immunohistochemical profile of the tumor cells. The tu-
mor was composed almost entirely of cells with ovoid to
spindle shaped nuclei with small foci of epithelial ele-
ments consisting of ducts and tubules. Myoepithelial car-
cinomas exhibit a wide spectrum of morphological heter-
ogeneity and for that reason could be confused with
many tumors. Differential diagnoses include myoepithe-
lioma, various sarcomas, interdigitating dendritic cell
sarcoma and melanoma9.
In the present case, malignant spindle cell pattern ini-
tially suggested a sarcoma, but immunohistochemical
study showed positive staining for vimentin, S-100 pro-
tein (Figure 1d) and alpha smooth muscle actin which in-
dicated a myoepithelial differentiation10,11. Cytokeratin
positivity was noticed in the ductal epithelial cells and in
the periductular myoepithelial cells, but it was absent
from malignant spindle cells. Immunohistochemical stai-
ning of tumor cells with antibodies to HMB-45 and CEA
was absent.
In the initial specimen and in all recurrence speci-
mens of the present case, large number of tumor cells nu-
clei was immunoreactive with p63, clone 4A4 (Figure 1c).
Benign myoepithelial cells of salivary glands, like those
of normal breast and prostate epithelium, express p6312.
In all salivary gland –derived tumor types that differenti-
ate towards luminal and myoepithelial lineages, p63 was
expressed in myoepithelial cells, whereas internal lumi-
nal cells were always negative13. This immunophenotype
confirms myoepithelial differentiation.
The combination of nuclear polymorphism and mi-
totic activity establishes a diagnosis of malignancy. Cellu-
lar proliferative activity is assessed by mitotic count and
the Ki-67 labelling index (Figure 1b). The tumor cells nu-
clei mean Ki-67 labelling index in the initial specimen
was 10% and in all recurrences the mean index was 20%.
The Ki-67 labelling index above 10% is said to be diag-
nostic of malignancy in a myoepithelial neoplasm7.
The infiltrative growth pattern with involvement of
bones was suggestive of but not in itself indicative of a
malignant tumor. There was no histological evidence of a
pre-existing adenoma or benign myoepithelioma in our
case, despite examination of multiple sections. In initial
resection tumor was not present at the surgical resection
margin, but unusual histology might indicate that a
more aggressive approach was necessary for this patient.
Most carcinomas arising de novo in parotid gland are
highly aggressive neoplasms, have a higher metastatic
potential and have tendency to recur locally following
surgical resection4. In our case, there was a short time
period between resection of the primary tumor and the
development of recurrences.
The clinical features of myoepithelial carcinomas are
as follows: most frequent involvement of the parotid
gland, followed by the submandibular gland; rapidly en-
larging mass with extensive invasion of the surrounding
tissue in some cases; low rate of cervical lymph node me-
tastasis but high rate of distant metastasis; frequent re-
currence after surgical excision; poor prognosis14.
Conclusion
We report a case of a rare malignant neoplasm of sali-
vary gland, a myoepithelial carcinoma, which arose de
novo in a parotid gland, was highly aggressive, character-
ized by infiltrative growth, with an unusually short time
period between resection of the primary tumor and the
development of recurrences.
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MIOEPITELNI KARCINOM PODU[NE @LIJEZDE
S A @ E T A K
Rijetki maligni tumor `lijezda slinovnica, mioepitelni karcinom, nastao de novo u desnoj podu{noj `lijezdi. Primarni
tumor je gra|en prete`no od polimorfnih malignih mioepitelnih stanica. Kasnije tumor recidivira tri puta a karakte-
rizira ga prodor u kosti baze lubanje. Histolo{ki pregled pokazuje sarkomatozni izgled tumora gra|enog od malignih
vretenastih stanica s brojnim mitozama i perineuralnom invazijom. U limfnim ~vorovima vrata ne nalazi se metastaza.
Imunohistokemijsko bojenje upu}uje na mioepitelnu diferencijaciju: tumorske stanice su pozitivne na monoklonska
protutijela za vimentin, alfa glatko-mi{i}ni aktin i S-100 protein, te `ari{no pozitivne na citokeratin (AE1/AE3). Brojne
jezgre tumorskih stanica su pozitivne na p63 protutijelo, klon 4A4, u svim resektatima. Mioepitelni karcinomi pokazuju
{irok spektar morfolo{ke raznolikosti, te se mogu zamijeniti s brojnim tumorima. Izgled stanica, na~in rasta i imuno-
histokemijski profil je odlu~uju}i za patohistolo{ku dijagnostiku. Ovi tumori su maligne neoplazme sa razli~itim kli-
ni~kim ishodom, ponekad vrlo agresivni.
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